What is the complication rate, including invasion and metastases, for a low-grade Squamous Cell Carcinoma (SCC) on the hand of an elderly female patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Complication Rate of Low-Grade SCC on the Hand in Elderly Females

For a low-grade (well-differentiated) squamous cell carcinoma on the hand of an elderly female, the metastatic risk is approximately 10%, which is significantly higher than the overall 3-5% metastatic rate for cutaneous SCC due to the high-risk anatomical location. 1, 2

Risk Stratification for This Specific Case

The hand represents a high-risk anatomical location that substantially increases complication rates compared to trunk or proximal extremity sites. 3 The combination of factors in this patient creates a moderate-to-high risk profile:

Favorable Prognostic Factor:

  • Low-grade (well-differentiated) histology: When the tumor is well-differentiated (grade I), the metastatic rate is only 10%, compared to 59% for moderately differentiated and 86% for poorly differentiated lesions. 1

Unfavorable Prognostic Factors:

  • Hand location: The hands are specifically designated as high-risk anatomic sites in multiple staging systems, associated with increased metastatic potential. 4, 5
  • Elderly age: While not independently predictive of worse outcomes, elderly patients (>75 years) have higher rates of metastatic disease in population studies. 4

Expected Complication Rates

Metastasis Risk:

  • Overall metastatic rate for cutaneous SCC: 3-5% in general populations 3, 6
  • For well-differentiated tumors on high-risk sites like the hand: Approximately 10% metastatic rate 1
  • Metastasis typically occurs within 2-3 years of primary diagnosis, most commonly to regional lymph nodes (epitrochlear and axillary nodes for hand lesions). 6

Local Recurrence Risk:

  • Local recurrence rate: Approximately 4.6% in large cohort studies, though this varies significantly with adequacy of initial excision. 2
  • Incomplete surgical excision is associated with substantially worse prognosis. 3

Disease-Specific Mortality:

  • Overall mortality from cutaneous SCC: 2.1% in large cohort studies 2
  • For well-differentiated tumors, mortality risk remains low but is elevated compared to non-high-risk anatomic sites. 1, 2

Critical Additional Risk Factors to Assess

The following features, if present, would dramatically increase complication rates and must be evaluated:

  • Tumor size ≥2 cm: Increases metastatic risk 7-fold and disease-specific death 15.9-fold 2
  • Depth of invasion >2 mm or invasion beyond subcutaneous fat: Associated with 9.3-fold increased metastasis risk and 13-fold increased mortality 2, 5
  • Perineural invasion: Increases disease-specific death 3.6-fold 2
  • Poor differentiation: If the tumor is actually moderately or poorly differentiated rather than well-differentiated, metastatic rates jump to 59-86% 1
  • Immunosuppression: Increases metastatic risk 2-3 times higher than immunocompetent patients 3, 4
  • Tumor recurrence: Recurrent tumors have substantially higher metastatic potential (up to 35% in high-risk cases) 6, 5

Clinical Implications

For a truly low-grade SCC on the hand, expect approximately 10% metastatic risk, 4-5% local recurrence risk, and low (<3%) disease-specific mortality. 1, 2 However, this assumes:

  • Complete surgical excision with clear margins 3
  • Confirmed well-differentiated histology 1
  • Tumor size <2 cm 2
  • Depth ≤2 mm 5
  • No perineural or lymphovascular invasion 2, 5

The hand location alone elevates this patient above the "typical" low-risk SCC category, warranting close surveillance every 3-6 months for the first 2-3 years when metastases are most likely to occur. 6

References

Research

Post-traumatic squamous-cell carcinoma.

The Journal of bone and joint surgery. American volume, 1990

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.

American journal of clinical dermatology, 2016

Research

High-risk cutaneous squamous cell carcinoma.

Actas dermo-sifiliograficas, 2012

Research

Epidemiology of advanced cutaneous squamous cell carcinoma.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.